{
  "docId": "019de076-9336-7344-93bc-154185328b25",
  "docSlug": "edea36d6b00ed662cafb2da1a03c41ae",
  "documentTitle": "BenevolentAI | Investor Conference Presentation Deck | 22 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 22,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 16,
  "notes": "The table presents normalized operating loss and EPS, excluding specific exceptional items as detailed in the footnotes.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-9336-7344-93bc-154185328b25/20",
  "deckHref": "/decks/019de076-9336-7344-93bc-154185328b25",
  "deckJsonHref": "/decks/019de076-9336-7344-93bc-154185328b25.json",
  "deckAnchorHref": "/decks/019de076-9336-7344-93bc-154185328b25#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.28,
        "x": 0.67,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "Revenue increase across AstraZeneca collaboration... R & D spend increase driven by advancing pipeline... The Group also has costs relate to BEN-2293... Bus Ops spend has increased...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3e6ddca5-e8b2-4ba7-afd5-a24394044744",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.05,
        "y": 0.87
      },
      "kind": "source-note",
      "text": "1. Excludes exceptional costs... 2. Normalised EPS also excludes taxation impact...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ac768bf7-56aa-4f4d-89f5-2d84973c2930",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.6,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "table",
      "text": "Revenue, R&D, G&A, Normalised operating loss, EPS, Shares outstanding",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1b8f1979-7933-451c-8240-b81ef2144def",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.06
      },
      "kind": "title",
      "text": "H1 2023 Financial highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ed480628-9c53-47f7-9d0a-73d1b3b374d7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 22,
      "from": 20,
      "beatId": "6e88ce7f-6a20-4169-9e35-7d0257207b12",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Financials",
      "beatSlug": "sequoia-pitch-financials",
      "evidence": "H1 2023 financial highlights and appendix data provide financial insights.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}